A study of adolescents with type 1 diabetes (T1D) found that real-time continuous glucose monitoring (CGM) with a predictive hypoglycemia alarm reduced the time spent below range.
The use of real-time continuous glucose monitoring (RT-CGM) with a predictive alarm for hypoglycemia significantly reduced the risk of hypoglycemic events among adolescents with type 1 diabetes (T1D), according to a study published in Diabetes, Obesity, and Metabolism.
RT-CGM devices have become a widely used tool for the management of diabetes in recent years, especially in children and young people with T1D, the authors noted. They have become the standard in glycometabolic control, including among those managing diabetes with multiple daily insulin injections (MDI), and they allow for the analysis of extensive data on current glucose levels to help with therapy decisions.
When used in tandem with an insulin pump, RT-CGM can improve and maintain glycemic control via an integrated system; the gold standard for patients not using an insulin pump is still intensified basal-bolus MDI. However, the authors explained that the latter management protocol can elevate the risk of hypoglycemic events. Predictive alarm technology offers a potential solution to improve management in these patients by making them aware of glycemic trends and influencing therapeutic habits.
The crossover, monocentric, randomized study evaluated the efficacy of RT-CGM with predictive alarm technology in a group of 20 adolescents with T1D based on time below range over 8 weeks, including a run-in period, a pair of 2-week treatment periods—1 period with a predictive alarm 20 minutes prior to a 70 mg/dl threshold and 1 period with an alarm on threshold (AoT) at 70mg/dl—and a 2-week washout period. Ten patients were randomized to first use AoT then a predictive alarm, and 10 first used the predictive alarm followed by the AoT. Hypoglycemia was defined as less than 70 mg/dl, and severe hypoglycemia was defined as <54 mg/dl.
When participants were using the predictive alarm, they spent less time in hypoglycemia and severe hypoglycemia. With the predictive alarm, there was a reduction of more than 40% in time spent below range in hypoglycemia and more than 60% in time spent in severe hypoglycemia. The percentage of time below range in hypoglycemia with the predictive alarm was 1.68 vs 2.90 with the AoT (P < .02) and the percentages of time spent below range in severe hypoglycemia were 0.32 and 0.91, respectively (P < .02).
There was also a lower number of hypoglycemic events when the predictive alarm was used (0.65% vs 5.8%; P ≤ .01). Fewer grams of simple sugar for correction were consumed with use of the predictive alarm, as well (30.1 vs 125.5; P < .01). There was also an improvement in glucose control in terms of hyperglycemia and glycemic variability, the authors noted.
The study’s main limitation was the small number of participants, as well as the inclusion of adolescents only, limiting its generalizability. However, the authors noted that the adolescent group is one of the most notoriously difficult to treat, potentially making the inclusion of adolescents only a strength.
“In our study, we showed how the use of the predictive technology for hypoglycemia could help to reduce the risk of having a hypoglycemic event with the predictive alarm set at 20 minutes before, reducing the burden because of the frequency of CGM alarms,” the authors wrote. “With the used predictive alarm setting (a relatively short time before the hypoglycemic event), the system was able to alert participants in time, to avoid hypoglycemia, as shown by the significant reduction of numbers of hypoglycemic events recorded.”
Reference
Marigliano M, Piona C, Mancioppi V, Morotti E, Morandi A, Maffeis C. Glucose sensor with predictive alarm for hypoglycaemia: Improved glycaemic control in adolescents with type 1 diabetes. Diabetes Obes Metab. Published online January 4, 2024. doi:10.1111/dom.15432
Surgery, Chemotherapy Considered Protective Survival Factors in Patients With OC, Liver Metastases
May 21st 2024Surgery and chemotherapy significantly improved both overall survival (OS) and cancer-specific survival (CSS) in patients with liver metastases originating from ovarian cancer (OC), who generally face a poor prognosis with a 5-year survival rate of less than 30%.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Exploring Critical Advances in ARDS, Asthma, Lung Cancer, Health Equity at ATS 2024
May 20th 2024During a session at the American Thoracic Society (ATS) 2024 International Conference, experts presented the most impactful data from the last year on acute respiratory distress syndrome (ARDS), childhood asthma, health equity, and lung cancer.
Read More